Resultado de búsqueda
Dr. Drucker received his M.D. from the University of Toronto in 1980, and is currently Professor of Medicine. He holds a Canada Research Chair in Regulatory Peptides and the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology.
Daniel Joshua Drucker (born 23 June 1956) is a Canadian endocrinologist. A Fellow of the Royal Society, he is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto.
Dr. Daniel Drucker is a clinician-scientist who develops treatments for diabetes, obesity, and intestinal disorders. He studies peptide hormones produced in the pancreas, gastrointestinal tract and brain. His lab has carried out basic research leading to two new treatments for type 2 diabetes and one new therapy for short bowel syndrome
Dr. Drucker received his M.D. from the University of Toronto in 1980, and is currently Professor of Medicine. He holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. His laboratory is based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto and studies the molecular biology and ...
Daniel J Drucker 1 , Jens J Holst 2. Affiliations. 1 Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. drucker@lunenfeld.ca.
1249. 2008. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor–dependent and–independent pathways. K Ban, MH Noyan-Ashraf, J Hoefer, SS Bolz, DJ Drucker, M Husain. Circulation 117 (18), 2340-2350.
A profoundly gifted laboratory researcher, Dr. Drucker has personally translated advanced scientific discoveries into real-world clinical applications, substantially improving the lives of patients.
